Precision medicine and the FDA's draft guidance on laboratory-developed tests

被引：9

作者：

Hwang, Thomas J. ^{[1
,2
]}

Lehmann, Lisa Soleymani ^{[3
,4
]}

Kesselheim, Aaron S. ^{[4
,5
]}

机构：

[1] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA

[2] Blackstone Grp, London, England

[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA

来源：

NATURE BIOTECHNOLOGY | 2015年 / 33卷 / 05期

基金：

英国生物技术与生命科学研究理事会; 日本学术振兴会; 欧洲研究理事会;

关键词：

CANCER;

D O I：

10.1038/nbt.3221

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：449 / 451

页数：4

共 9 条

[1] MISSING THE MARK [J].

Buchen, Lizzie .

NATURE, 2011, 471 (7339) :428-432

[2]

Holtzman N.A., 1997, FINAL REPORT TASK FO

[3] Quantifying The Food And Drug Administration's Rulemaking Delays Highlights The Need For Transparency [J].

Hwang, Thomas J. ;

Avorn, Jerry ;

Carpenter, Daniel ;

Kesselheim, Aaron S. .

HEALTH AFFAIRS, 2014, 33 (02) :309-315

[4] Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].

Kwak, Eunice L. ;

Bang, Yung-Jue ;

Camidge, D. Ross ;

Shaw, Alice T. ;

Solomon, Benjamin ;

Maki, Robert G. ;

Ou, Sai-Hong I. ;

Dezube, Bruce J. ;

Jaenne, Pasi A. ;

Costa, Daniel B. ;

Varella-Garcia, Marileila ;

Kim, Woo-Ho ;

Lynch, Thomas J. ;

Fidias, Panos ;

Stubbs, Hannah ;

Engelman, Jeffrey A. ;

Sequist, Lecia V. ;

Tan, WeiWei ;

Gandhi, Leena ;

Mino-Kenudson, Mari ;

Wei, Greg C. ;

Shreeve, S. Martin ;

Ratain, Mark J. ;

Settleman, Jeffrey ;

Christensen, James G. ;

Haber, Daniel A. ;

Wilner, Keith ;

Salgia, Ravi ;

Shapiro, Geoffrey I. ;

Clark, Jeffrey W. ;

Iafrate, A. John .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703

[5]

Nelson C, 2014, MMWR-MORBID MORTAL W, V63, P333

[6] FDA pushes for control over laboratory-developed tests [J].

Ratner, Mark .

NATURE BIOTECHNOLOGY, 2014, 32 (09) :855-855

[7]

Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]

[8]

Souverijn JHM, 2014, NEW ENGL J MED, V371, P187, DOI [10.1056/NEJMc1405215, 10.1056/NEJMoa1311194]

[9]

US Food and Drug Administration, 2014, DRAFT GUID FRAM REG

← 1 →